Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
belzutifan 40 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
somapacitan 10 mg/1.5 mL injection, pen device |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
amivantamab 350 mg/7 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
damoctocog alfa pegol 1000 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
damoctocog alfa pegol 3000 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
damoctocog alfa pegol 2000 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
damoctocog alfa pegol 500 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
damoctocog alfa pegol 250 units injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
enfortumab vedotin 20 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
lenacapavir 300 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
enfortumab vedotin 30 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
lenacapavir 463.5 mg/1.5 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
acalabrutinib 100 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
avatrombopag 20 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pemetrexed 1 g/40 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pemetrexed 100 mg/4 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pemetrexed 500 mg/20 mL injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
tofacitinib 11 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 23% + cannabidiol less than 1% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 20.9% + cannabidiol less than 1% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 21.4% + cannabidiol less than 1% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
delta-9-tetrahydrocannabinol 24.6% + cannabidiol less than 1% bud |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
rivaroxaban 1 mg/mL granules |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
voriconazole 40 mg/mL powder for oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing with silver 10 cm x 10 cm hydroactive dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
aprotinin 3000 KI units/mL + factor XIII 10 units/mL + fibrinogen 110 mg/mL + human thrombin 4 units/mL + calcium chloride dihydrate 4.4 mg/mL solution |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing with silver 12.5 cm x 12.5 cm hydroactive dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dressing with silver 10 cm x 10 cm tulle dressing |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
tigecycline 50 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
sulfacetamide sodium 10% eye drops |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
eucalyptus oil 8.8% + menthol liquid 3.8% + methyl salicylate 28.3% cream |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
typhoid fever polysaccharide vaccine 25 microgram/0.5 mL injection, syringe |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
eucalyptus oil 8.8% + menthol liquid 3.8% + methyl salicylate 28.3% gel |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
travoprost 0.004% eye drops |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
butyl hydroxybenzoate 0.2% + light liquid paraffin 10% + salicylic acid 1.3% + zinc oxide 10% powder |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pizotifen 500 microgram tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
glycerophosphate calcium 88 mg/10 mL (equivalent to 16.72 mg of calcium) + glycerophosphate ferric 21.75 mg/10 mL (equivalent to 3.3 mg of elemental iron) + glycerophosphate manganese 2 mg/10 mL (equivalent to 488 microgram of manganese) + glycerophosphate potassium 10.61 mg/10 mL (equivalent to 2.74 mg of potassium) + glycerophosphate sodium 10.61 mg/10 mL (equivalent to 1.59 mg of sodium) + liver extract 38.67 mg/10 mL + thiamine hydrochloride 1.19 mg/10 mL oral liquid |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
valine with carbohydrate containing 50 mg valine powder for oral liquid, 4 g sachet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
chloroxylenol 0.3% + triclosan 0.3% cream |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
fluoxetine 20 mg dispersible tablet |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
dihydrocodeine tartrate 19 mg/10 mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dihydrocodeine tartrate 120 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
valine with carbohydrate containing 1 g valine powder for oral liquid, 4 g sachet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
pseudoephedrine hydrochloride 120 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 20% (100 g/500 mL) injection, bag |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dihydrocodeine tartrate 60 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
povidone-iodine 1% mouthwash |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 10% (50 g/500 mL) injection, bottle |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
disulfiram 200 mg tablet |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
pseudoephedrine hydrochloride 60 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 20% (20 g/100 mL) injection, bag |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
povidone-iodine 10% application, tube |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
essential amino acids formula with vitamins and minerals powder for oral liquid, 12.5 g sachet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
dihydrocodeine tartrate 90 mg modified release tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 30% (75 g/250 mL) injection, bottle |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
retinol palmitate 3500 units + colecalciferol 5.5 microgram + dl-alpha-tocopherol 10.2 mg (11.333 units) + ascorbic acid 125 mg + cocarboxylase tetrahydrate 5.8 mg + riboflavin sodium phosphate 5.67 mg + pyridoxine hydrochloride 5.5 mg + cyanocobalamin 6 microgram + folic acid 414 microgram + dexpanthenol 16.15 mg + biotin 69 microgram + nicotinamide 46 mg injection, vial |
Is a |
False |
medicinal product unit of use |
Inferred relationship |
Some |
|
roxithromycin 300 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 30% (99.9 g/333 mL) injection, bag |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
drotrecogin alfa (activated) 20 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 20% (200 g/L) injection, bottle |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
povidone-iodine 5% cream |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
drotrecogin alfa (activated) 5 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 20% (100 g/500 mL) injection, bottle |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
clozapine 25 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
anidulafungin 100 mg injection, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 30% (99.9 g/333 mL) injection, bottle |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ethanol 45% + lidocaine 2.5% + salicylic acid 1.5% + tannic acid 2% + rheum palmatum 15% paint |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
roxithromycin 150 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
povidone-iodine 10% (22.5 cm x 7.5 cm) dressing, 1 pad |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
glycopyrronium 50 microgram powder for inhalation, 1 capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
clozapine 50 mg/mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
vismodegib 150 mg capsule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ivabradine 7.5 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
concentrated compound gentian infusion 0.1 mL/mL + sodium bicarbonate 50 mg/mL oral liquid |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 30% (150 g/500 mL) injection, bottle |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ascorbic acid 80 mg + biotin 10 microgram + calcium (as hydrogen phosphate) 70 mg + cyanocobalamin 5 microgram + d-alpha-tocopheryl acid succinate 8.6 mg (10 units) + iron (as ferrous fumarate) 5 mg + folic acid 100 microgram + iodine 99 microgram + magnesium (as oxide heavy) 38 mg + manganese (as sulfate monohydrate) 2 mg + nicotinamide 25 mg + pantothenic acid (as calcium pantothenate) 9.2 mg + pyridoxine hydrochloride 4 mg + riboflavin 10 mg + thiamine hydrochloride 10 mg + zinc (as sulfate monohydrate) 2 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
clozapine 100 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
cabergoline 500 microgram tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
ivabradine 5 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
methyl salicylate 30% + menthol 8% cream |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 30% (75 g/250 mL) injection, bag |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
cabergoline 2 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
methyl salicylate 12.74% + menthol 5.88% cream |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
leflunomide 10 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 20% (20 g/100 mL) injection, bottle |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
clozapine 200 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
methylene blue 50 mg/5 mL injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 10% (50 g/500 mL) injection, bag |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
calcium carbonate 420 mg + glycine 180 mg chewable tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
acetylcysteine 2 g/10 mL inhalation solution, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 20% (50 g/250 mL) injection, bag |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
repaglinide 2 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
sodium tetradecyl sulfate 0.5% (10 mg/2 mL) injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
acetylcysteine 1 g/5 mL inhalation solution, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
clozapine 50 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
sodium tetradecyl sulfate 1% (20 mg/2 mL) injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
acetylcysteine 800 mg/4 mL inhalation solution, vial |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
soya oil 20% (200 g/L) injection, bag |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
repaglinide 500 microgram tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
sodium tetradecyl sulfate 3% (60 mg/2 mL) injection, ampoule |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|
acetylcysteine 600 mg tablet |
Is a |
True |
medicinal product unit of use |
Inferred relationship |
Some |
|